Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus

Nat Clin Pract Rheumatol. 2008 Jul;4(7):352-3. doi: 10.1038/ncprheum0815. Epub 2008 May 13.

Authors

Hai Feng Pan¹, Dong Qing Ye, Xiang Pei Li

Affiliation

¹ Department of Epidemiology and Biostatistics, Anhui Provincial Hospital, Hefei, Anhui, China.

PMID: 18477998
DOI: 10.1038/ncprheum0815

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Humans
Interleukin-17 / metabolism
Lupus Erythematosus, Systemic / immunology*
T-Lymphocyte Subsets / drug effects
T-Lymphocyte Subsets / immunology
T-Lymphocyte Subsets / metabolism
T-Lymphocytes, Helper-Inducer / drug effects
T-Lymphocytes, Helper-Inducer / immunology*
T-Lymphocytes, Helper-Inducer / metabolism

Substances

Interleukin-17